Cardiovascular Systems Inc. (CSII)

43.81
0.18 0.41
NASDAQ : Health Technology
Prev Close 43.99
Open 43.29
Day Low/High 42.90 / 43.80
52 Wk Low/High 24.84 / 46.52
Volume 117.87K
Avg Volume 282.60K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.60B
EPS 0.10
P/E Ratio 764.83
Div & Yield N.A. (N.A)
Cardiovascular Systems (CSII) Weak On High Volume Today

Cardiovascular Systems (CSII) Weak On High Volume Today

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a weak on high relative volume candidate

Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems To Webcast Fiscal 2016 Second-Quarter Earnings Conference Call Thursday, January 21

Cardiovascular Systems To Webcast Fiscal 2016 Second-Quarter Earnings Conference Call Thursday, January 21

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2016 second-quarter conference call on Thursday, January 21, 2016, at 3:45 p.

Commit To Purchase Cardiovascular Systems At $12.50, Earn 23% Annualized Using Options

Commit To Purchase Cardiovascular Systems At $12.50, Earn 23% Annualized Using Options

Investors considering a purchase of Cardiovascular Systems, Inc shares, but tentative about paying the going market price of $14.23/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2016 put at the $12.50 strike, which has a bid at the time of this writing of $1.45.

Cardiovascular Systems CEO To Take Medical Leave

Cardiovascular Systems CEO To Take Medical Leave

Cardiovascular Systems (CSI) (NASDAQ: CSII) said today that, effective Dec.

Weak On High Volume: Cardiovascular Systems (CSII)

Weak On High Volume: Cardiovascular Systems (CSII)

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a weak on high relative volume candidate

Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems Enrolls First Patients In OPTIMIZE Study

Cardiovascular Systems Enrolls First Patients In OPTIMIZE Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced that the first two patients have been enrolled in its OPTIMIZE, peripheral Orbital Atherectomy System (OAS) study.

Relative Strength Alert For Cardiovascular Systems

Relative Strength Alert For Cardiovascular Systems

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems To Webcast Fiscal 2016 First-Quarter Earnings Conference Call Wednesday, November 4

Cardiovascular Systems To Webcast Fiscal 2016 First-Quarter Earnings Conference Call Wednesday, November 4

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2016 first-quarter conference call on Wednesday, November 4, 2015, at 3:45 p.

Trade-Ideas: Cardiovascular Systems (CSII) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Cardiovascular Systems (CSII) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a "dead cat bounce" (down big yesterday but up big today) candidate

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Cardiovascular Systems Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Cardiovascular Systems Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Cardiovascular Systems Inc.

Cardiovascular Systems (CSII) Stock Tanks on Preliminary First Quarter Results

Cardiovascular Systems (CSII) Stock Tanks on Preliminary First Quarter Results

Cardiovascular Systems (CSII) shares are down 20% after the company reported preliminary first quarter earnings that missed its own previous guidance.

Cardiovascular Systems Reports Preliminary Fiscal First-Quarter Financial Results

Cardiovascular Systems Reports Preliminary Fiscal First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today reported preliminary results for its fiscal 2016 first quarter ended September 30, 2015.

Interesting CSII Put And Call Options For October 16th

Interesting CSII Put And Call Options For October 16th

Investors in Cardiovascular Systems, Inc saw new options begin trading this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CSII options chain for the new October 16th contracts and identified one put and one call contract of particular interest.

Cardiovascular Systems Discloses Health Condition Of CEO, Dave Martin

Cardiovascular Systems Discloses Health Condition Of CEO, Dave Martin

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) said today that its President and CEO, David Martin, has recently been diagnosed with cancer and is undergoing treatment.

Cardiovascular Systems To Participate In Morgan Stanley Global Healthcare Conference

Cardiovascular Systems To Participate In Morgan Stanley Global Healthcare Conference

Cardiovascular Systems (NASDAQ:CSII) will attend the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2015.

Peripheral Arterial Disease: A Disease Marked By Leg Pain And Wounds On Legs And Feet

Peripheral Arterial Disease: A Disease Marked By Leg Pain And Wounds On Legs And Feet

September marks peripheral arterial disease (PAD) awareness month.

CSII: Insiders vs. Shorts

CSII: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/15/2015 settlement date, and Cardiovascular Systems, Inc is one of the most shorted stocks of the Russell 3000, based on 6.70 "days to cover" versus the median component at 5.74. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Commit To Buy Cardiovascular Systems At $20, Earn 15.6% Annualized Using Options

Commit To Buy Cardiovascular Systems At $20, Earn 15.6% Annualized Using Options

Investors eyeing a purchase of Cardiovascular Systems, Inc stock, but tentative about paying the going market price of $22.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $20 strike, which has a bid at the time of this writing of $1.10.

Cardiovascular Systems Enters Oversold Territory (CSII)

Cardiovascular Systems Enters Oversold Territory (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems Reports Fiscal 2015 Fourth-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2015 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems To Webcast Fiscal 2015 Fourth-Quarter Earnings Conference Call Wednesday, August 5

Cardiovascular Systems To Webcast Fiscal 2015 Fourth-Quarter Earnings Conference Call Wednesday, August 5

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2015 fourth-quarter conference call on Wednesday, August 5, 2015, at 3:45 p.

Cardiovascular Systems Completes Coast Study Enrollment

Cardiovascular Systems Completes Coast Study Enrollment

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that it has completed enrollment for its Coronary Orbital Atherectomy System Trial (COAST) study.

13 Stocks to Buy for the Second Half of 2015

13 Stocks to Buy for the Second Half of 2015

Analysts have been busy issuing research, offering investors suggestions on stocks to buy or sell for the second half of the year. Here are 13 more stocks to consider buying.

FDA Clears Next-Generation Guide Wire For Cardiovascular Systems' Peripheral Orbital Atherectomy Systems

FDA Clears Next-Generation Guide Wire For Cardiovascular Systems' Peripheral Orbital Atherectomy Systems

Cardiovascular Systems, Inc. (NASDAQ:CSII) (CSI), today announced that it has received FDA clearance for its new ViperWire Advance ® Peripheral Guide Wire with Flex Tip for their Peripheral Orbital Atherectomy Systems...

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems To Present At William Blair & Company's 35th Annual Growth Stock Conference

Cardiovascular Systems To Present At William Blair & Company's 35th Annual Growth Stock Conference

On Thursday, June 11, 2015, Cardiovascular Systems' (NASDAQ: CSII) President and Chief Executive Officer, David L.

TheStreet Quant Rating: C (Hold)